Cassava Sciences- Warrants (15/11/2024) Total Liabilities

As of the most recent data (September 2026), SAVAW shows a total liabilities of $42M. That compares with $48M in the prior-year period — down 12.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAVAW's total liabilities is now $42M (was $48M) — a 12.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cassava Sciences- Warrants (15/11/2024) is outperforming or lagging.

Tracking SAVAW's total liabilities over time shows whether Cassava Sciences- Warrants (15/11/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $42M That compares with $48M in the prior-year period — down 12.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Cassava Sciences- Warrants (15/11/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $42M) with ownership activity and broader fundamentals.

Cassava Sciences- Warrants (15/11/2024)'s total liabilities is $42M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.